{"id":714719,"date":"2022-11-23T16:18:07","date_gmt":"2022-11-23T21:18:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\/"},"modified":"2022-11-23T16:18:07","modified_gmt":"2022-11-23T21:18:07","slug":"augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\/","title":{"rendered":"Augmedix to Attend the Benchmark 2022 Discovery One-on-One Investor Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SAN FRANCISCO, Nov.  23, 2022  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=d45ZqoDkZMD74um-ugiN__PCDZTgUlqFkArt0I4UZ6sJa7PnBS8-cyvidLG7AEJfb9niam5yEiMMnrXRfzEv7g==\" rel=\"nofollow noopener\" target=\"_blank\"><strong><u>Augmedix<\/u><\/strong><\/a><strong> In<\/strong><strong>c. (Nasdaq: AUGX)<\/strong>, a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced the Company will participate in Benchmark Company\u2019s 11<sup>th<\/sup> Annual Discovery One-on-One Investor Conference to be held Thursday, December 1, 2022 at the New York Athletic Club in New York City. Augmedix\u2019s management will participate in one-on-one meetings with institutional analysts and investors throughout the day.<\/p>\n<p align=\"left\">The conference offers emerging growth and dynamic publicly traded companies access to institutional investors and analysts in a one-on-one format.<\/p>\n<p align=\"left\">To schedule a one-on-one meeting with Augmedix Inc., you may submit your request online via the link provided upon registration. To register for the conference, please visit Benchmark\u2019s event page at: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uc72wFSPSQfvz_Anq5O6PrxibwIuyBPSTuDy4jvai-ydrEIVX3aptD9DNc1TmxhFD06Dmk2zhYQ6DhkokB4TxT-RqJSaPpYU9XMhpmfnMaY1SMf-dNhjax4TOaSIX2s6lzUGZVjYU7CpHa2ZU4BbjuPc8XQXcjgj8FJxO25BjBH9dDchPdoS5NV2VnJySu8Gm7ubew3stQAREQwrulsrZGPygFTdTU4kdeGPKhVExUwt7d-SxK-67tsiw6_jp9_RxJL-XZ0Yh6nL5yKIQ67PUopnHH8fHcefhfCU_KtsOUqgSrIEPXGPiEi9sL6CYvc1XF1LgAfs8XBtrtW1mvi0uw==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.benchmarkcompany.com\/news-events\/upcoming-events\/the-11th-annual-discovery-one-on-one-investor-conference<\/a>.<\/p>\n<p align=\"left\">\n        <strong>About Augmedix<\/strong><br \/>\n        <br \/>Augmedix (Nasdaq: AUGX) delivers industry-leading, ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners.<\/p>\n<p align=\"left\">Augmedix is on a mission to help clinicians and patients form a human connection at the point of care without the intrusion of technology. Augmedix\u2019s solutions extract data from natural physician-patient conversations and convert it to medical notes in real time, which are seamlessly transferred to the EHR. To achieve this, the company\u2019s Ambient Automation Platform uses Automated Speech Recognition and Natural Language Processing, supported by medical documentation specialists.<\/p>\n<p align=\"left\">Leveraging this platform, Augmedix\u2019s solutions relieve clinicians of administrative burden, in turn, reducing burnout and increasing both clinician and patient satisfaction. Augmedix is also leading the revolution in leveraging point-of-care data by making connections between millions of physician-patient interactions and analyzing them to deliver actionable insights that elevate patient care.<\/p>\n<p align=\"left\">Augmedix is headquartered in San Francisco, CA, with offices around the world. To learn more, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jTGOVDSUHi_b3qpikesOivX3Si1s9cC0IoCSqPK5t5a9ocX7y5ncrTuTMFuvmk_v6ByvCO4wdm4SWGS236XnVg==\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.augmedix.com<\/u><\/a>.<\/p>\n<p align=\"left\">Investors:<br \/>Ji-Yon Yi<br \/>Gilmartin Group<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EkK9gL7HL_-q8rHNx9sWt3TNntBWWxwivMItasWIwZnTnyggiU6QP6cspKVHZfV8JzqxVUOeLOXpiAIgVI1MLd_viuwq1nI_LzqFd05NblI=\" rel=\"nofollow noopener\" target=\"_blank\"><u>investors@augmedix.com<\/u><\/a><\/p>\n<p align=\"left\">Media:<br \/>Kaila Grafeman<br \/>Augmedix<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0rGuzkbHN8E7TKfj9jGsoJWGAXPNgceL54Rov7INSWZhiCPh0ZgRlZLj0Fkj4HG6R3xRf11qYvjSrXZVzA6l8Q==\" rel=\"nofollow noopener\" target=\"_blank\"><u>pr@augmedix.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjc2MiM1MjgwNzM0IzIyMDY0NTM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MDU1MzdjMGItNjY0MS00ZWVhLWFmNTgtYWE3MTY0N2E2YTg5LTEyMTgwMDY=\/tiny\/Augmedix-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN FRANCISCO, Nov. 23, 2022 (GLOBE NEWSWIRE) &#8212; Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced the Company will participate in Benchmark Company\u2019s 11th Annual Discovery One-on-One Investor Conference to be held Thursday, December 1, 2022 at the New York Athletic Club in New York City. Augmedix\u2019s management will participate in one-on-one meetings with institutional analysts and investors throughout the day. The conference offers emerging growth and dynamic publicly traded companies access to institutional investors and analysts in a one-on-one format. To schedule a one-on-one meeting with Augmedix Inc., you may submit your request online via the link provided upon registration. To register for the conference, please visit Benchmark\u2019s &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Augmedix to Attend the Benchmark 2022 Discovery One-on-One Investor Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-714719","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Augmedix to Attend the Benchmark 2022 Discovery One-on-One Investor Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Augmedix to Attend the Benchmark 2022 Discovery One-on-One Investor Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN FRANCISCO, Nov. 23, 2022 (GLOBE NEWSWIRE) &#8212; Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced the Company will participate in Benchmark Company\u2019s 11th Annual Discovery One-on-One Investor Conference to be held Thursday, December 1, 2022 at the New York Athletic Club in New York City. Augmedix\u2019s management will participate in one-on-one meetings with institutional analysts and investors throughout the day. The conference offers emerging growth and dynamic publicly traded companies access to institutional investors and analysts in a one-on-one format. To schedule a one-on-one meeting with Augmedix Inc., you may submit your request online via the link provided upon registration. To register for the conference, please visit Benchmark\u2019s &hellip; Continue reading &quot;Augmedix to Attend the Benchmark 2022 Discovery One-on-One Investor Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-23T21:18:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjc2MiM1MjgwNzM0IzIyMDY0NTM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Augmedix to Attend the Benchmark 2022 Discovery One-on-One Investor Conference\",\"datePublished\":\"2022-11-23T21:18:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\\\/\"},\"wordCount\":316,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODcwMjc2MiM1MjgwNzM0IzIyMDY0NTM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\\\/\",\"name\":\"Augmedix to Attend the Benchmark 2022 Discovery One-on-One Investor Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODcwMjc2MiM1MjgwNzM0IzIyMDY0NTM=\",\"datePublished\":\"2022-11-23T21:18:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODcwMjc2MiM1MjgwNzM0IzIyMDY0NTM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODcwMjc2MiM1MjgwNzM0IzIyMDY0NTM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Augmedix to Attend the Benchmark 2022 Discovery One-on-One Investor Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Augmedix to Attend the Benchmark 2022 Discovery One-on-One Investor Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\/","og_locale":"en_US","og_type":"article","og_title":"Augmedix to Attend the Benchmark 2022 Discovery One-on-One Investor Conference - Market Newsdesk","og_description":"SAN FRANCISCO, Nov. 23, 2022 (GLOBE NEWSWIRE) &#8212; Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced the Company will participate in Benchmark Company\u2019s 11th Annual Discovery One-on-One Investor Conference to be held Thursday, December 1, 2022 at the New York Athletic Club in New York City. Augmedix\u2019s management will participate in one-on-one meetings with institutional analysts and investors throughout the day. The conference offers emerging growth and dynamic publicly traded companies access to institutional investors and analysts in a one-on-one format. To schedule a one-on-one meeting with Augmedix Inc., you may submit your request online via the link provided upon registration. To register for the conference, please visit Benchmark\u2019s &hellip; Continue reading \"Augmedix to Attend the Benchmark 2022 Discovery One-on-One Investor Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2022-11-23T21:18:07+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjc2MiM1MjgwNzM0IzIyMDY0NTM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Augmedix to Attend the Benchmark 2022 Discovery One-on-One Investor Conference","datePublished":"2022-11-23T21:18:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\/"},"wordCount":316,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjc2MiM1MjgwNzM0IzIyMDY0NTM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\/","name":"Augmedix to Attend the Benchmark 2022 Discovery One-on-One Investor Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjc2MiM1MjgwNzM0IzIyMDY0NTM=","datePublished":"2022-11-23T21:18:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjc2MiM1MjgwNzM0IzIyMDY0NTM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODcwMjc2MiM1MjgwNzM0IzIyMDY0NTM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/augmedix-to-attend-the-benchmark-2022-discovery-one-on-one-investor-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Augmedix to Attend the Benchmark 2022 Discovery One-on-One Investor Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/714719","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=714719"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/714719\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=714719"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=714719"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=714719"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}